Surveillance of influenza-like illness in Belgian nursing homes by unknown
Arch Public Health 
2010, 68, 100-108 
 
 
1  Scientific Institute of Public Health, Directorate Public Health and Surveillance, Brussels, Belgium 
 beatrice.jans@wiv-isp.be 
Surveillance of influenza-like illness  
in Belgian nursing homes 
 by 
Jans B1, Latour K1, Broex E1, Catry B1 
 
Keywords 
Nursing homes, surveillance, influenza, A(H1N1)2009, influenza-like illness, seasonal flu 
Introduction 
Elderly often combine several risk factors that influence the course and severity of an influ-
enza infection. The World Health Organization strongly recommends vaccination of elderly 
living in care facilities. Even if vaccine effectiveness seems to decline with age (1), several 
studies (2-3) show that vaccination reduces the risk for pneumonia, hospitalisation and death 
during an influenza epidemic. Vaccination is also important among nursing home (NH) staff 
in close contact with this frail population. Studies have provided evidence that NHs with high 
vaccination coverage among health care workers (HCW) have a lower mortality and morbid-
ity among residents (4-7). Belgian data on the incidence of influenza-like illness (ILI) and on 
vaccination among NH residents and HCW are scarce. Hence, during the A(H1N1)2009 
pandemic, a small pilot sentinel network of NHs was set up in order to collect epidemiological 
data on ILI and vaccination coverage among NH residents and HCW.  
Methods 
Aims of this surveillance  
- to measure the incidence of ILI in Belgian NH residents during the influenza season 
of 2009-2010,  
- to collect quantitative data on vaccination coverage for A(H1N1)2009 and seasonal 
flu as well as on absenteeism for ILI among HCW in NHs during the same observa-
tion period. 
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Setup of the surveillance 
The Scientific Institute of Public Health (WIV-ISP) invited all Belgian NHs (n=1,606) to volun-
tarily participate in a national network for the surveillance of all new cases of ILI. A local 
surveillance contact person was designated in each participating facility.  
The enrolment form completed by the local contact person provided general descriptive in-
formation on the NH such as the total bed capacity and the number of staff members 
employed. The latter group was split up in four professional categories: nursing/care staff, 
paramedical, logistic and administrative staff.  
Case definition of ILI 
ILI was defined as a condition including some or all of the following symptoms: fever, chills, 
myalgias, vomiting, headache, loss of appetite and/or cough. At the start of the surveillance, 
virological confirmation of A(H1N1)2009 cases was no longer routinely performed, making it 
impossible to distinguish between A(H1N1)2009 and seasonal flu.  
Collected data 
The collected resident data for each new ILI case were: year of birth, date of onset of the first 
symptoms, prescribed treatment (antiviral, antibiotic or other), presence of comorbidity (dia-
betes, chronic pulmonary disease, impaired immunity, severe/moderate cardiac illness, renal 
disease or hepatic disease), course of illness (recovered, hospitalised, complication, death 
attributable to ILI or death by other cause) and presence of an earlier ILI episode since June 
2009.  
The total number of resident-days during the period was collected as denominator.  
Following data concerning the NH staff were registered at the end of each observation pe-
riod: the cumulative number of staff members by professional category that have been 
vaccinated against A(H1N1)2009 and seasonal flu and the total number of staff members by 
professional category absent for ILI (or complications).  
Surveillance period 
The surveillance period (1 November 2009 – 31 March 2010) was split into ten observation 
periods of 2 weeks each (from the 1st until the 14th and from the 15th until the end of each 
month). All enrolled NHs were invited to participate throughout all 10 periods in order to ob-
tain data covering the whole observation period. When no cases of ILI were registered during 
the surveillance period, the surveyor had to indicate “0% incidence” in a  specific data field. If 
this information was missing, participants were contacted by mail or phone in order to con-
firm the ‘zero incidence’ reporting. 
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Data transmission 
Participants used the available electronic datasheet or a paper form questionnaire which was 
optically read. At the end of each observation period, a reminder for data delivery was sent to 
the NHs. 
Calculated indicators 
The following indicators were calculated:  
- The total number of new ILI cases per 1000 resident-days (incidence density) during 
the observation period. Missing resident-days per period were replaced by an esti-
mated number of resident-days, based on the total NH bed capacity and an estimated 
bed occupancy rate of 98% corresponding with the average rate observed in other 
recent Belgian NH studies. 
- For each professional category: 
- the proportion of staff members absent for ILI (or complications);  
- the proportion of staff members vaccinated against A(H1N1)2009 and seasonal flu. 
Data were processed using STATA version 9. 
Ethical issues 
To assure confidentiality, the WIV-ISP provided a unique NH study number to each partici-
pating facility. The local contact person allotted a unique resident study number to each ILI 
case. Resident names were not communicated to the WIV-ISP.  
Results 
Participation 
A total of 28 NHs delivered surveillance data. Three facilities were excluded since resident 
data were missing for some surveillance periods. Finally, 25 NHs representing 2,483 NH 
beds (mean: 99.3 beds/NH, range: 30-193) and 366,605 resident-days provided surveillance 
data covering the 10 observation periods.  
Surveillance of ILI among NH residents  
Total number of reported ILI cases and incidence density 
A total of 47 residents developed an ILI episode during the surveillance period. The global ILI 
incidence density reached 0.13 ILI cases/1000 resident-days (Figure 1). The first case oc-
curred on 2 November 2009, the last one on 16 February 2010. In 19 out of 25 participating 
NHs (76%), zero cases of ILI were registered. All 47 reported ILI cases occurred in 6 facilities 
(range: 1-30 cases/NH). Four of these facilities reported only one single ILI case occurring 
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early in this ILI surveillance (between 3 November and 3 December: sporadic cases, Figure 
1).  
Most ILI cases (91.5%) were clustered in 2 NHs with a global incidence density of 1.82 
cases/1000 resident-days (n=13 cases) in NH-1 (epidemic NH-1, Figure 1) and 1.79/1000 
resident-days (n=30 cases) in NH-2 (epidemic NH-2, Figure 1). 
Figure 1. Incidence of influenza-like illness (ILI) among residents in a sentinel nursing home network 
November 2009-March 2010 
sporadic cases: < 2 ILI cases/NH/season 
epidemic cases: ≥ 2 ILI cases/NH/season 
Characteristics of residents with ILI 
Residents with ILI had a mean age of 85.6 years (range: 70-101). Comorbidity (risk factors) 
was present in 80.9% (n=38) of all ILI cases and was often multiple since 23 out of 38 resi-
dents at risk (60.5%) cumulated 2 or more comorbid conditions. The main risk factors in 
descending order were moderate cardiac illness (n=21), immunodeficiency (n=16), chronic 
pulmonary disease (n=13), moderate renal disease (n=10), diabetes (n=9) and chronic he-
patic disease (n=6). 
Among the residents with ILI, 95.7% were vaccinated against seasonal flu and 87.2% against 
A(H1N1)2009. For 4 out of 6 residents not vaccinated against A(H1N1)2009, ILI appeared 
between 2 and 6 November, just before the official A(H1N1)2009 vaccination campaign 
started in Belgian NHs (7 November 2009). 
Two residents with ILI were treated with an antiviral drug, while 35 residents (74.5%) re-
ceived an antibiotic. Nine residents with ILI received another type of treatment (antipyretic, 
analgesic,...) and one received no treatment at all.  
Five residents with ILI died (10.6%) but according to the records only for one resident death 
was directly attributable to ILI. The fatal case was a 91-year-old immunodeficient resident, 
ILI cases among residents in 25 NHs: November 2009 ‐ March 2010
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not vaccinated against A(H1N1)2009. All fatal cases occurred in epidemic NH-2 which had a 
case fatality rate of 16.7%. Complications occurred in 36.2% (n=17) of all ILI cases. Only one 
complicated case required hospitalisation. Of all residents with ILI, 42.5% (n=20) were admit-
ted to the hospital. Nineteen came from epidemic NH-2. In this NH 63.3% of all ILI cases 
were hospitalised. Detailed information on residents with ILI is provided in table 1. 
Table 2. Characteristics of sporadic and epidemic cases of residents with influenza-like illness (ILI) 
November 2009-March 2010 
 









Number of cases 4 13 30 47 
Mean age (years) 82.8 89.9 84.1 85.6 
Date of first / last ILI case 3 Nov / 3 Dec 2 Nov / 15 Feb 15 Nov / 16 Feb 2 Nov / 16 Feb 
Risk factors (comorbidity)     
No risk factor 1 (25.0%) 2 (15.4%) 6 (20.0%) 9 (19.1%) 
Only 1  2 (50.0%) 5 (38.5%) 8 (26.7%) 15 (31.9%) 
2 or more  1 (25.0%) 6 (46.2%) 16 (53.3%) 23 (48.9%) 
Vaccination status     
Seasonal flu 4 (100.0%) 12 (92.3%) 29 (96.7%) 45 (95.7%) 
A(H1N1)2009 2 (50.0%) 10 (76.9%) 29 (96.7%) 41 (87.2%) 
Treatment for ILI     
Antiviral only 2 (50.0%) 0 (0.0%) 0 (0.0%) 2 (4.3%) 
Antibiotic only 1 (25.0%) 9 (69.2%) 25 (83.3%) 35 (74.5%) 
Other only (antipyretic, analgesic,...) 1 (25.0%) 3 (23.1%) 5 (16.7%) 9 (19.1%) 
No treatment 0 (0.0%) 1(7.7%) 0 (0.0%) 1 (2.1%) 
Clinical issue§     
Deceased* 0 (0.0%) 0 (0.0%) 5 (16.7%) 5 (10.6%) 
Hospitalised 0 (0.0%) 1 (7.7%) 19 (63.3%) 20 (42.6%) 
Complication 1 (25.0%) 11 (84.6%) 5 (16.7%) 17 (36.2%) 
§ not mutually exclusive 
* 1 death directly attributable to ILI 
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Surveillance of ILI among NH staff  
Data on absenteeism for ILI (or complication) and vaccination coverage for seasonal flu and 
A(H1N1)2009 among nursing home workers were available for 20 NHs. 
Absenteeism for ILI 
The global mean proportions of staff members absent for ILI during the 5 months of follow-up 
were not significantly different between professional categories and reached 4.5% among 
nursing staff (n=45 cases from 10 NHs, 95%CI: 3.61-5.53), 5.3% in the paramedical staff 
(n=6 cases from 1 NH, 95%CI: 4.28-6.40), 4.9% among the logistic staff (n=18 cases from 6 
NHs, 95%CI: 3.97-5.97) and 4.3% in administrative personnel (n=7 cases from 2 NHs, 
95%CI: 3.43-5.31). The highest attack rates for ILI among nurses, paramedical staff and ad-
ministrative personnel were registered in epidemic NH-2 reaching 32%, 100% and 55% 
respectively.  
Vaccination coverage for seasonal flu and A(H1N1)2009 
Nineteen NHs provided data about the vaccination coverage for seasonal flu among NH staff 
members. Table 2 describes the vaccination coverage for both variants per professional 
category.  
 
Table 2. Vaccination coverage for A(H1N1)2009 (n= 20 NHs) and seasonal flu (n=19 NHs)  
by professional category during flu season 2009-2010 
Professional 
category Staff members Staff vaccinated for seasonal flu 
 n n % Range/NH Mean % 95% CI 
Nursing care  1010 380 37.6 0-87.5% 43.7% 40.85-46.69
Paramedical 119 50 42.0 0-100% 48.5% 45.44-51.76
Logistic 396 156 39.4 0-100% 49.0% 45.97-52.16
Administrative 77 30 39.0 0-100% 53.2% 49.92-56.54
  Staff vaccinated for A(H1N1)2009 
Nursing care  1029 436 42.4% 0-93.3% 38.8% 36.14-41.52
Paramedical 122 40 32.8% 0-100% 35.8% 33.22-38.52
Logistic 389 164 42.2% 0-100% 45.5% 42.54-48.50
Administrative 74 34 45.9% 0-100% 52.2% 49.08-55.46
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The nursing staff, in closest contact with the frail elderly, had the lowest mean vaccination 
coverage for seasonal flu: 43.7% (95%CI: 40.85-46.69) while 48.5% (95%CI: 45.44-51.76) 
and 49% (95%CI: 45.97-52.16) of the paramedics and logistic staff members respectively 
were immunised. Vaccination coverage was the highest amongst administrative staff mem-
bers (53.2%, 95%CI: 49.92-56.54). 
For A(H1N1)2009 the vaccination coverage was even lower since only 38.8% (95%CI: 
36.14-41.52) and 35.8% (95%CI: 33.2-38.5%) of the nurses and paramedical staff respec-
tively were protected (n=20 NHs). The administrative and logistic staff had the highest mean 
vaccination coverage: 52.2% (95%CI: 49.08-55.46) and 45.5% (42.54-48.50) respectively.  
Surprisingly, in NHs which reported residents with ILI during the flu season, the vaccination 
coverage for A(H1N1)2009 amongst nurses was higher (44.8%, 95%CI: 17.13-72.55) com-
pared to NHs without ILI cases among residents (36.3%, 95%CI: 20.76-51.87). 
In NHs with ILI cases (n=6 NHs) nurses were also more frequently (50.3%, 95%CI: 31.54-
68.98) vaccinated for seasonal flu compared to nurses in NHs without cases (n=14 NHs) 
(40.9%, 95%CI: 26.94-54.82). These differences were not statistically significant and confi-
dence intervals were often large due to small numbers in some subcategories. 
Discussion 
During the flu season 2009-2010 the incidence of ILI cases among NH residents was very 
low and similar to trends observed in the general population. The epidemic curve of partici-
pating NHs showed three distinct phenomena:  
- A zero ILI prevalence for 19 NHs,  
- Four NHs with only one ILI case during the flu season. These sporadic cases 
emerged early when some NH residents were not yet vaccinated for A(H1N1)2009,  
- Two facilities with an ILI epidemic (43 of 47 total ILI cases) with the highest peak at 
the end of January 2010. These epidemic cases emerged spread over a large period 
of time and extinguished mid February 2010. 
Despite important vaccination rates for both influenza variants among cases, these residents 
developed an ILI episode anyway. Some of the early ILI cases, which occurred in vaccinated 
residents, could be explained by the short time span between vaccination and the onset of 
the ILI. Also, the ‘antibody response’ induced by vaccination among elderly is described to be 
lower (clinical vaccine efficacy: 17-53%) than among younger adults (clinical efficacy: 70-
90%) (8).  
Risk factors for the acquisition of ILI were frequently present and often multiple among resi-
dents. This may explain why 75% of the cases received an antibiotic treatment, which is not 
advisable for viral infections in the general population. In epidemic NH-2, the proportion of 
residents receiving antibiotics was even higher (83%). Another possible explanation for the 
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important proportion of ILI cases receiving antibiotics could be the relatively high number of 
cases with a complications, especially in epidemic NH-1 reaching 84.6%.  
In epidemic NH-2 the hospitalisation rate of cases with ILI was surprisingly high (63.3%) de-
spite a relatively low number of complications (16.7%). In this same NH the mortality among 
ILI cases was important (16.7%), but according to the records only for one resident death 
was directly attributable to ILI. This very aged, immunocompromised resident was not vacci-
nated against A(H1N1)2009. A different vaccination strategy for NH residents in terminal or 
palliative care could be an explanation for this, but further investigation is needed.  
In participating NHs, the vaccination coverage rate for seasonal flu and for A(H1N1)2009 
among HCWs directly involved in resident care (nurses) was low: 38.8% and 43.7% on aver-
age. In scientific literature vaccination rates of less than 50% are mentioned (9).  
The vaccination coverage for both variants was better among administrative staff members 
than among nurses. 
During this flu season the mean proportion of HCW on sick leave for ILI was not significantly 
different between the professional categories, but varied strongly by NH. In epidemic NH-2, 
the total paramedical staff, half of the administrative personnel and one third of the nursing 
care staff was absent for ILI. 
This surveillance provided interesting data, but the relatively small study sample (25 NHs) 
and the low incidence of ILI did not allow us to investigate in more detail the possible rela-
tionship between vaccination coverage among nurses and the incidence of ILI and 
associated complications and mortality among residents.  
One of the difficulties in this surveillance was to convince NHs to send data while cases were 
scarce or absent. Another weakness was the absence of vaccination coverage data for both 
influenza variants in the total NH-population.  
‘Resident-days’ as a denominator for calculation of the ILI incidence was often missing and 
replaced by an estimated number of resident-days assuming that the bed occupancy rate 
was comparable between institutions. Other data were also difficult to obtain: e.g. if vaccina-
tion of an HCW was carried out by the personal general practitioner, the institution did not 
record this. Finally, several participants were not able to provide data on absenteeism of 
HCW for ILI, since the reasons for sick leave of HCWs were confidential.  
Strengths of this surveillance were the low associated workload, the ‘easy-to-use’ methodol-
ogy.  
This continuous ILI surveillance in NHs provides important data on the severity degree of ILI 
in the population with the highest risk in terms of morbidity and mortality, namely elderly liv-
ing in collectivity in which vaccination is less effective due to immunosenescence. The results 
of this surveillance could lead to a more rational and specific management of ILI in these fa-
cilities.  
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